Effect of low-calcium and standard-calcium dialysate on serum calcium, phosphorus and full-segment parathyroid hormone in patients on peritoneal dialysis: A retrospective observational study

被引:1
作者
An, Ning [1 ]
Zhou, Haishan [1 ]
Li, Xianhui [1 ]
Yu, Xinyin [1 ]
Yang, Haijuan [1 ]
Zhai, Liping [1 ]
Huang, Yuhua [1 ]
Yao, Cuiwei [1 ,2 ]
机构
[1] Guangdong Med Univ, Affiliated Hosp, Dept Nephrol, Zhanjiang, Peoples R China
[2] Guangdong Med Univ, Dept Nephrol, Affiliated Hosp, 57th South Renmin Rd, Zhanjiang 524001, Guangdong, Peoples R China
关键词
Chronic kidney disease; serum calcium; serum phosphorus; peritoneal dialysis; vascular calcification; low-calcium dialysis; CHRONIC KIDNEY-DISEASE; RISK; CALCIFICATION; PROGRESSION; PHOSPHATE;
D O I
10.1177/03913988231206641
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: To investigate the effects of low-calcium and standard-calcium dialysate in patients with chronic kidney disease on peritoneal dialysis, and find out which dialysate has less vascular calcification effect.Methods: A total of 141 patients who had undergone peritoneal dialysis (PD) for 2 years in the PD centre from January 2012 to December 2017 were included and divided into two groups according to the calcium concentration of the PD fluid used. There were 79 cases in the low-calcium group, with a dialysate calcium concentration of 1.25 mmol/L and 62 cases in the standard-calcium group, with a dialysate calcium concentration of 1.75 mmol/L. The demographic characteristics and clinical information before initiation of PD were collected and compared between the two groups. Information on the serum calcium, phosphorus and PTH, systolic and diastolic blood pressures and the use of antihypertensive and phosphate-lowering drugs in the second year of dialysis was also collected and compared between the two groups. Vascular calcification was assessed in patients on PD treatment.Results: The mean serum calcium concentrations before initiation of PD in the low- and standard-calcium groups were 1.94 +/- 0.27 and 1.89 +/- 0.28 mmol/L, respectively. The serum calcium concentrations after PD were 2.30 +/- 0.21 and 2.41 +/- 0.23 mmol/L, respectively. After PD, the serum calcium concentration in both groups was significantly increased (p < 0.05). The serum calcium concentration in the low-calcium group after PD treatment was lower than that in the standard-calcium group, and the difference was statistically significant (p < 0.05). Compared with the standard-calcium group, patients in the low-calcium group had significantly higher parathyroid hormone concentrations (p < 0.05). More types of phosphate-lowering drugs were used (59.49%) in the low-calcium group than that in the standard-calcium group (35.48%; p < 0.05). The number of antihypertensive drug usage were also higher in the low-calcium group, and the difference was statistically significant (p < 0.05). As for the vascular calcification effect, the two groups have shown no statistical difference in abdominal aortic calcification rate, carotid arteriosclerosis rate and aortic arch calcification rate (p < 0.05).Conclusion: We found that low-calcium PD fluid may increase the PTH level and the proportion of CKD patients using antihypertensive drug and phosphorus-lowering drug, but the vascular calcification effect of the low and standard calcium PD fluid needs further exploration. This paper provides new evidence for the choice of dialysate for PD, low-calcium dialysate has no outstanding advantages for long term dialysis.
引用
收藏
页码:539 / 546
页数:8
相关论文
共 32 条
  • [21] Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management
    Shirazian, Shayan
    Grant, Candace D.
    Aina, Olufemi
    Mattana, Joseph
    Khorassani, Farah
    Ricardo, Ana C.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2017, 2 (01): : 94 - 107
  • [22] Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease
    Stubbs, Jason R.
    He, Nan
    Idiculla, Arun
    Gillihan, Ryan
    Liu, Shiguang
    David, Valentin
    Hong, Yan
    Quarles, L. Darryl
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (01) : 38 - 46
  • [23] Tsai CC., 2018, MEDICINE, V97
  • [24] Vikrant Sanjay, 2016, Indian J Endocrinol Metab, V20, P460, DOI 10.4103/2230-8210.183457
  • [25] Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients
    Wee, Hwee-Lin
    Seng, Benjamin Jun Jie
    Lee, Jia Jia
    Chong, Kok Joon
    Tyagi, Pallavi
    Vathsala, Anantharaman
    How, Priscilla
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2016, 14
  • [26] Xu ZM., 2000, CHIN J ARTERIOSCLER, V8, P165
  • [27] Yamamoto H., 2008, PERIT DIAL INT, V28
  • [28] Yang J., 2015, CHIN J KIDNEY DIS IN, V4, P246
  • [29] Prevalence and outcomes associated with hypocalcaemia and hypercalcaemia among pre-dialysis chronic kidney disease patients with mineral and bone disorder
    Yong, Mei Hui Amanda
    Seng, Jun Jie Benjamin
    Tan, Ying Lin Cheryl
    Wong, Jiunn
    How, Priscilla
    [J]. SINGAPORE MEDICAL JOURNAL, 2024, 65 (08) : 421 - 429
  • [30] Correlations of cardiac function with inflammation, oxidative stress and anemia in patients with uremia
    Zhang, Heping
    Fan, Lei
    Liao, Huawei
    Tu, Lirong
    Zhang, Jie
    Xu, Dan
    Feng, Jiangchao
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (03)